The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy

E-ISSN： 1875-5607|13|5|643-652

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.5, 2013-04, pp. : 643-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lentiviral Vectors for Anti-Tumor Immunotherapy

Current Gene Therapy, Vol. 8, Iss. 6, 2008-12 ,pp. : 438-448

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Monoclonal Antibodies in Conjunction with &bgr;-Glucans: A Novel Anti- Cancer Immunotherapy

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4298-4305

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer / Anti-Tumor

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 1-24

Bentham Science Publishers

Access to resources Recommend Favorite

MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 344-352

Bentham Science Publishers

Access to resources Recommend Favorite

Polymeric micelles as nanocarriers for drug delivery

By Qiu Liyan Zheng Cheng Jin Yi Zhu Kangjie

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 819-830

Informa Healthcare

Access to resources Recommend Favorite